Chester County News and Community Website
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), headquartered in West Chester, PA, is a dermatology therapeutics company developing medications for skin diseases requiring medical interventions. For more information, visit www.verrica.com.
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its participation in two key healthcare investor conferences this May in New York.
Verrica Pharmaceuticals to Present at Upcoming Investor Conferences Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced a conference call and live webcast for 8:30 a.m. ET, May 13, 2024, to update investors and discuss its first-quarter …
Verrica Pharmaceuticals to Discuss Q1 Financial Results in Upcoming Webcast Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced its participation in the 23rd Annual Needham Virtual Healthcare Conference, setting the stage for a detailed presentation by Ted White, …
Verrica Pharmaceuticals to Spotlight Innovations at Needham Healthcare Conference Read More WEST CHESTER, PA — In a significant development for Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), the company announced its lead dermatological product, YCANTH™, has been granted New Chemical Entity (NCE) Status …
Verrica Pharmaceuticals Secures Key FDA Designation for YCANTH, Enhancing Market Protection Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a prominent player in the field of dermatology therapeutics, is set to take center stage at the TD Cowen 44th Annual …
Verrica Pharmaceuticals Set to Illuminate TD Cowen Healthcare Conference with Fireside Chat Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a trailblazing company in the field of dermatology therapeutics, has announced it will host a conference call and live webcast at …
Verrica Pharmaceuticals Set to Discuss Q4 and Full-Year 2023 Financial Results in Upcoming Conference Call Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has achieved a significant milestone in its commercial strategy. The Centers for Medicare & Medicaid Services (CMS) has issued a permanent …
Verrica Pharmaceuticals Earns Key CMS Approval, Streamlining Access to Molluscum Contagiosum Treatment Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leader in dermatology therapeutics, announced a significant development in its ongoing research for innovative skin cancer treatments. The company confirmed …
Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has announced that it received the minutes from its recent Type C meeting with the U.S. Food and Drug Administration (FDA). …
Verrica Pharmaceuticals Gains FDA Alignment for YCANTH’s Phase 3 Clinical Development Plan Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced this week that it has entered into an agreement with Walgreens Co. The deal will see YCANTH™, the first FDA-approved …
Verrica Pharmaceuticals Expands Distribution Network for YCANTH with Walgreens Partnership Read More